Many new names sounded as if they’d been cooked up by a medieval monk. HIV-1 would henceforth be known as Lentivirus ...

Kindeva Drug Delivery, a global CDMO, and Emervax, developer of a circular RNA-based vaccine platform (emxRNA), entered an ...

Despite innovations and some impressive national responses, the covid-19 pandemic revealed limitations and gaps in efforts at national and global levels to prepare for and respond to health ...

Kindeva Drug Delivery, a global CDMO and drug delivery expert, and Emervax, a developer of a proprietary circular RNA-based vaccine platform (emxRNATM), today announced an exclusive partnership to ...

INOVIO , a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today highlighted ...

Pharmaceuticals and vector-control programmes have greatly diminished the once-widespread disease, but sustained effort will ...

The federal government has strengthened surveillance at major international airports in Nigeria to guide against the outbreak of Human Metapneumovirus (HMPV) recently discovered in China.

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the 'Company'), comments on the many viruses that could cause pandemics ...

SHELTON, CT / ACCESSWIRE / January 8, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), comments on the many viruses that could cause pandemics that are go ...

Ebola virus, one of the deadliest pathogens, has a fatality rate of about 50%, posing a serious threat to global health and safety.

Little is yet known about how this process works. A research ... Probability Training: Preventing Errors of Reasoning in Medicine and Law Nov. 6, 2024 — A new study shows how students can better ...

Ebola virus, one of the deadliest pathogens, has a fatality rate of about 50%, posing a serious threat to global health and safety. To address this challenge, researchers have developed the first ...